Securities Intellectual Property Health

Read need-to-know updates, commentary, and analysis on Securities issues written by leading professionals.
News & Analysis as of

Introducing a New Drug Into the Marketplace in the Lifecycle of a Pre-Sales Revenue Biotechnology Venture Destined for IPO Success

Mindful that this series of articles describes biotech ventures that are ripe for initial public offerings even before launching an income-producing drug product into the commercial market, the paramount objective for all...more

Court Report - October 2014

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Shire LLC v. Amerigen Pharmaceuticals Ltd. 1:14-cv-06095; filed October , 2014 in the District Court of New Jersey....more

Expect Focus - Regulators Are Watching: New Products, New Opportunities, New Risks - Volume III, Summer 2014

In This Issue: - IN THE SPOTLIGHT ..Standard CGL Policy Form Adds Data Breach Coverage Exclusion - LIFE INSURANCE ..Class Claims Against Lincoln National Barred in Section 419 Action – Again ...more

The Life Sciences Report - Spring 2014

In this issue: - A New Accelerator Takes Digital Health Start-Ups to the Next Level - The Return of the MedTech IPO Market - Is There a Deal in Your Future? A Guide to Navigating Antitrust Waters -...more

White Collar Watch - May 2013

In This Issue: - SEC Charges Municipal Bond Issuer with Securities Fraud for Misleading Statements on Issuer’s Website - State v. Brown Affords Managers in the Mortgage Processing Industry a Cautionary Tale -...more

"Skadden's 2012 Insights, January 2012: Global Litigation"

In This Issue: - 58 U.S. Supreme Court Cases to Watch - 59 Securities Litigation: Recent Supreme Court Decisions and Future Trends - 66 Continued Step-up in Government Investigations and White Collar Crime...more

6 Results
|
View per page
Page: of 1

Follow Securities Updates on: